mS-11, a mimetic of the mSin3-binding helix in NRSF, ameliorates social interaction deficits in a prenatal valproic acid-induced autism mouse model
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 176, 1-5
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (JP16K08268)
- Japan Society for the Promotion of Science (JP26293020)
- Japan Society for the Promotion of Science (JP17H03989)
- Japan Society for the Promotion of Science (JP17K19488)
- Ministry of Education, Culture, Sports, Science and Technology (JP18H05416)
- Ministry of Education, Culture, Sports, Science and Technology (JP18dm0107122h0003)
- Ministry of Education, Culture, Sports, Science and Technology (JP18dm0207061h0002)
- New Energy and Industrial Technology Development Organization
- Osaka University
- PRISM BioLab Co., Ltd.
- Dainippon Sumitomo Pharma
- Takeda Science Foundation
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
- Japan Agency for Medical Research and Development (JP18am0101084j0002)
This publication has 40 references indexed in Scilit:
- The role of epigenetic modifications in neurodevelopmental disorders: A systematic reviewNeuroscience & Biobehavioral Reviews, 2018
- Epigenetics and Autism Spectrum Disorder: Is There a Correlation?Frontiers in Cellular Neuroscience, 2018
- An update on pharmacotherapy of autism spectrum disorder in children and adolescentsInternational Review of Psychiatry, 2018
- Psychopharmacological interventions in autism spectrum disorderExpert Opinion on Pharmacotherapy, 2016
- Rearrangement of the dendritic morphology in limbic regions and altered exploratory behavior in a rat model of autism spectrum disorderNeuroscience, 2013
- Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood AutismJAMA, 2013
- Antiepileptic drugs in migraine: from clinical aspects to cellular mechanismsTrends in Pharmacological Sciences, 2007
- Autism spectrum disorders: developmental disconnection syndromesCurrent Opinion in Neurobiology, 2007
- S-2-PENTYL-4-PENTYNOIC HYDROXAMIC ACID AND ITS METABOLITE S-2-PENTYL-4-PENTYNOIC ACID IN THE NMRI-EXENCEPHALY-MOUSE MODEL: PHARMACOKINETIC PROFILES, TERATOGENIC EFFECTS, AND HISTONE DEACETYLASE INHIBITION ABILITIES OF FURTHER VALPROIC ACID HYDROXAMATES AND AMIDESDrug Metabolism and Disposition, 2006
- Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cellsThe EMBO Journal, 2001